Home › Myotonic Dystrophy › North Carolina
Myotonic Dystrophy clinical trials in North Carolina
4 studies for Myotonic Dystrophy are looking for participants at sites in North Carolina.
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
- Rare Disease Research, LLC, Hillsborough
RecruitingPhase 3
Ages 16 and older · All sexes · Updated Oct 1, 2026 · NCT07486934Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
- Rare Disease Research, LLC, Hillsborough
RecruitingPhase 3
Ages 4 to 18 · Men · Updated May 27, 2026 · NCT07608432Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
- Wake Forest University Health Sciences, Winston-Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Jan 23, 2026 · NCT07362875Biomarker Development for Muscular Dystrophies
- Wake Forest University, Winston-Salem
RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older · All sexes · Updated Nov 24, 2025 · NCT05019625From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.